glp-1 receptor agonist with dpp-4 inhibitor combination not recommended do combine inhibitors agonists guidance Why are DPP-4 ( do not combine dpp-4 inhibitors
Description
Fate Chem
Diabetologia (1990) 33:1157
Diabetes care 27 (8), 18791884
The greater impact on morbidity and mortality of diabetes in patients who develop the condition at a younger age compared to those who develop it later [77]
As a weight management drug, it slows down gastric emptying to prolong the feeling of being full and promotes a feeling of satiety in the brain to reduce cravings
